Pfizer-BioNTech COVID-19 Vaccine: Clinical Materials for Ages 5 Through 11 Years

Pfizer-BioNTech COVID-19 Vaccine

Clinical Materials for Ages 5 Through 11 Years

The U.S. Food and Drug Administration FDA has authorized a COVID-19 vaccine for children 5 through 11 years of age, and CDC’s Advisory Committee on Immunization Practices (ACIP) has new recommendations on vaccinating this population. Below is a list of new clinical materials related to these recommendations: 

• The Pfizer-BioNTech COVID-19 Vaccine Standing Orders for Administering Vaccine to Persons 5 through 11 Years of Age 
• The Pfizer-BioNTech COVID-19 Vaccine Preparation and Administration Summary form (Persons 5 through 11 Years of Age) 
• The Pfizer-BioNTech COVID-19 Vaccine Storage and Handling Summary (5 through 11 years of age) 
• The Pfizer-BioNTech COVID-19 Vaccine Storage and Handling labels (5 through 11 years of age) 
• The Pfizer-BioNTech COVID-19 Vaccine Beyond Use Date guidance and labels (5 through 11 years of age) 
• The Pfizer-BioNTech COVID-19 Vaccine Transporting Vaccine for Vaccination Clinics Held at Satellite, Temporary or Off-Site Locations (5 through 11 years of age) 

For more clinical information and materials, visit https://www.cdc.gov/vaccines/covid-19/info-by-product/pfizer/index.html.